Klivira
Request demo

Aimovig Prior Authorization for Gastroenterology: Navigating Co-Morbidities and PA Complexity

While Aimovig (erenumab) is primarily indicated for migraine prevention, gastroenterology practices often encounter the administrative complexities of managing prior authorizations for patients with diverse co-morbidities. Klivira helps streamline Aimovig prior authorization for gastroenterology patients, even when the medication falls outside the direct clinical scope of GI.

Revenue cycle directors and prior authorization coordinators in gastroenterology face a high volume of PAs for biologics, procedures, and specialty GI drugs. When patients present with co-morbid conditions like chronic or episodic migraine, managing prior authorizations for medications such as Aimovig adds another layer of administrative burden. Klivira's platform is designed to provide comprehensive PA automation, addressing both specialty-specific and broader patient medication needs.

Understanding Aimovig and its Role in Co-Morbid Patient Care

Aimovig (erenumab) is a CGRP receptor antagonist indicated for the preventive treatment of chronic and episodic migraine. While not a medication for gastrointestinal conditions, GI patients frequently manage multiple health issues. Effective prior authorization processes must account for the full spectrum of a patient's prescribed therapies, regardless of the prescribing specialty, to ensure continuity of care and appropriate reimbursement.

Navigating Prior Authorization for Non-GI Medications in a Gastroenterology Setting

Gastroenterology practices, especially those within larger health systems, may find their prior authorization teams responsible for coordinating or processing PAs for medications prescribed by other specialists. This requires a robust system capable of handling diverse drug classes and payer requirements, ensuring that administrative hurdles for drugs like Aimovig do not impede patient access to essential preventive therapies.

General Prior Authorization Considerations for Aimovig

  • Diagnosis of chronic or episodic migraine.
  • Documentation of prior trials and failures of conventional preventive migraine therapies (step therapy compliance).
  • Clinical rationale for CGRP receptor antagonist use.
  • Typically managed by neurology or primary care, but coordination may involve GI practice PA teams.

The Broader Prior Authorization Landscape in Gastroenterology

Gastroenterology already contends with significant prior authorization volume across various categories. High-PA-burden categories include IBD biologics (e.g., TNF inhibitors, integrin inhibitors, IL-12/23 inhibitors), hepatitis C direct-acting antivirals, advanced imaging (e.g., MR enterography), and specific endoscopic procedures like capsule endoscopy. Managing this existing complexity alongside PAs for non-GI drugs like Aimovig necessitates efficient automation.

Common Prior Authorization Hurdles in Gastroenterology

  • Step therapy requirements for IBD biologics (e.g., failure of conventional therapy, biosimilar mandates).
  • Documentation gaps for disease severity (e.g., Mayo score, CDAI) or pre-initiation screenings (TB, hepatitis).
  • Fibrosis stage or genotype documentation for Hep C DAAs.
  • Medical necessity criteria for advanced imaging or capsule endoscopy.

Klivira's Platform: Comprehensive Prior Authorization Automation for Multi-Specialty Environments

Klivira's prior authorization automation platform is built to manage the full spectrum of PA requests, from high-volume GI biologics to medications for co-morbid conditions like Aimovig. By integrating with EMRs and payer portals, Klivira streamlines documentation, applies payer-specific policy logic, and tracks authorization status, reducing administrative burden across all patient care pathways within your health system or practice.

Frequently asked questions

Why would a gastroenterology practice encounter Aimovig prior authorization?

While Aimovig is for migraine prevention, patients in gastroenterology practices often have co-morbid conditions. If a GI practice is part of a larger health system or manages patient medications comprehensively, their PA team may need to coordinate or process prior authorizations for non-GI drugs like Aimovig prescribed by other specialists.

What are the typical documentation requirements for Aimovig prior authorization?

Prior authorization for Aimovig generally requires documentation of a chronic or episodic migraine diagnosis, evidence of prior trials and failures of conventional preventive migraine therapies (step therapy), and a clear clinical rationale for CGRP antagonist use. These requirements are typically aligned with neurology or primary care guidelines.

How does Klivira help with prior authorizations for non-GI drugs like Aimovig?

Klivira's platform provides a centralized system for managing all prior authorizations, regardless of specialty. By integrating with your EMR, it can identify necessary documentation, apply payer-specific rules for drugs like Aimovig, and automate submission and tracking, thereby reducing manual effort for your PA coordinators across diverse medication types.

Can Klivira handle both pharmacy and medical benefit prior authorizations?

Yes, Klivira is designed to manage prior authorizations for medications covered under both pharmacy and medical benefits. This is crucial for specialties like gastroenterology, where biologic agents for IBD can switch between provider-administered infusions (medical benefit) and self-administered injections (pharmacy benefit), and for drugs like Aimovig which are typically pharmacy benefit.

What are the primary PA challenges Klivira addresses for gastroenterology?

For gastroenterology, Klivira addresses high-volume PA categories like IBD biologics (including step therapy and re-authorization), Hepatitis C DAAs (genotype, fibrosis stage), and complex procedures/imaging. It also helps manage the administrative burden of non-GI medications for co-morbidities by centralizing and automating the PA workflow.

Related coverage

Other aimovig prior authorization by payer

Other aimovig prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo